PE39996A1 - Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar - Google Patents

Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar

Info

Publication number
PE39996A1
PE39996A1 PE1995272089A PE27208995A PE39996A1 PE 39996 A1 PE39996 A1 PE 39996A1 PE 1995272089 A PE1995272089 A PE 1995272089A PE 27208995 A PE27208995 A PE 27208995A PE 39996 A1 PE39996 A1 PE 39996A1
Authority
PE
Peru
Prior art keywords
nicotine
ansia
smoking
symptoms
absence
Prior art date
Application number
PE1995272089A
Other languages
English (en)
Inventor
Satyanarayana Majeti
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE39996A1 publication Critical patent/PE39996A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

QUE COMPRENDE : A) DE 0,1 gm A 2 mg DE NICOTINA, B) DE 3 mg A 20 mg DE CAFEINA O EQUIVALENTE DE CAFEINA XANTINA; C) UNO O MAS VEHICULOS FARMACEUTICAMENTE ACEPTABLES ADECUADOS PARA LA ADMINISTRACION NASAL DIRECTA O INDIRECTA, D) UNO O MAS COMPUESTOS AROMATICOS SELECCIONADOS DEL GRUPO QUE CONSISTE DE MENTOL, EUCALIPTOL, TIMOL, ACEITE DE HOJA DE CEDRO, ACEITE DE MIRISTICA, ACEITE DE LAVANDA, ACEITE DE NUEZ MOSCADA, TREMENTINA, Y MEZCLAS DE ESTOS, E) DE 0.01% A 5% DE UN HUMECTANTE; Y F) DE 0,5% A 10% DE UN AGENTE TENSOACTIVO . EN DONDE LA COMPOSICION SE ENCUENTRA EN FORMA DE UNA EMULSION CON BASE DE UNGUENTO, DE UN GEL NASAL, EN FORMA DE SOLIDO EN DONDE SE INHALAN LOS VAPORES DEL SOLIDO
PE1995272089A 1994-06-23 1995-06-22 Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar PE39996A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26466694A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
PE39996A1 true PE39996A1 (es) 1996-10-03

Family

ID=23007084

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995272089A PE39996A1 (es) 1994-06-23 1995-06-22 Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar

Country Status (6)

Country Link
AU (1) AU2702795A (es)
IL (1) IL114130A0 (es)
MA (1) MA23586A1 (es)
PE (1) PE39996A1 (es)
WO (1) WO1996000069A1 (es)
ZA (1) ZA955033B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034605A1 (en) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
WO2001041732A1 (en) * 1999-12-06 2001-06-14 Gore Stanley L Compositions and methods for intranasal delivery of active agents to the brain
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
WO2004104490A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (de) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4959380A (en) * 1988-12-19 1990-09-25 Wilson Jordan E Method of treating people to stop smoking and composition
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency

Also Published As

Publication number Publication date
ZA955033B (en) 1996-02-15
WO1996000069A1 (en) 1996-01-04
MA23586A1 (fr) 1995-12-31
IL114130A0 (en) 1995-10-31
AU2702795A (en) 1996-01-19

Similar Documents

Publication Publication Date Title
BR9812615A (pt) Composições farmacêutica para tratar vìcio de tabaco ou vìcio de nicotina, para aliviar os sintomas da abstinência de nicotina ou para facilitar a cessação de fumar, para tratar vìcio de cocaìna e efeitos da abstinência associados, para tratar dependência alcoólica e efeitos da abstinência associados, e, processos para tratar vìcio de tabaco ou vìcio de nicotina, para aliviar os sintomas de abstinência de nicotina ou para facilitar a cessação de fumar, para tratar vìcio de cocaìna e efeitos da abstinência associados e, para tratar dependência alcoólica e efeitos da abstinência associados
BRPI0317463B8 (pt) composto, composição farmacêutica compreendendo o mesmo e uso do referido composto no preparo de um medicamento para tratar uma doença amilóide de transtiretina
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
ES2135460T3 (es) Composicion para ayudar a dejar de fumar.
ES2004856A4 (es) Agente tensioactivo pulmonar natural, procedimiento de preparacion y composiciones farmaceuticas.
NL194748B (nl) Osmotische doseringsvorm voor behandeling van cardiovasculaire ziekten.
ES2160707T3 (es) Composiciones que comprenden agentes deteriorantes del adn y p53.
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
FI963696A (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
NO990595D0 (no) Anvendelse av chelateringsmiddelet clikinol ved fremstilling av en farmas°ytisk sammensetning for behandling av alzheimers sykdom
DE68924537D1 (de) Zusammensetzung zur behandlung der symptome verursacht durch beseitigung von tabak.
PE39996A1 (es) Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
BR0010515A (pt) Sistema terapêutico de ministração transdérmica, processo para mascarar um odor desagrádavel e uso de um óleo essencial em um sistema terapéutico de ministração transdérmica
PE11399A1 (es) Combinacion de loratadina y un descongestionante para el tratamiento del asma
PT90249A (pt) Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t
BR0311747A (pt) Composição farmacêutica, forma de dose simples ou de múltiplas doses da composição, kit, e, método para tratar doença
PE20040080A1 (es) Combinaciones de epinastina, belladona y pseudoefefrina como nuevas formulaciones farmaceuticas
NO20012310D0 (no) Optisk aktiv pyridyl-4H-1,2,4-oksazdiazinderivat og dets anvendelse ved behandling av karsykdommer
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
ES2039433T3 (es) Una formulacion farmaceutica.
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
BR9802153A (pt) Método de obtenção e uso do extrato da rosmarinus officinalis,no tratamento de várias doenças.
BR0109770A (pt) Uso de galantamina para o tratamento do comportamento neuropsiquiátrico associado com a doença de alzheimer
NO990450L (no) Behandling av sinnslidelser

Legal Events

Date Code Title Description
FD Application declared void or lapsed